Similar to fibroblasts from patients with other mitochondrial diseases (Fig 1E), we found that CIII‐BCS1L fibroblasts express low levels of ATPIF1, suggesting the possibility that the lack of endogenous hydrolysis inhibition contributes to EPI efficacy in these cells. Here, ATP5IF1 is linked to mitochondrial disease.